blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1756034

EP1756034 - ANTIBIOTIC COMPOUND [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.05.2013
Database last updated on 26.04.2025
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
Merck Sharp & Dohme de Espana S.A.
Josefa Valcarcel, 38
28027 Madrid / ES
[N/P]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
For all designated states
Merck Sharp & Dohme de Espana S.A.
Josefa Valcarcel, 38
28027 Madrid / ES
Former [2012/32]For all designated states
Schering Corporation
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
Merck Sharp & Dohme de Espana S.A.
Josefa Valcarcel, 38
28027 Madrid / ES
Former [2010/10]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
For all designated states
Merck Sharp & Dohme de Espana S.A.
Josefa Valcarcel, 38
28027 Madrid / ES
Former [2007/09]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
Merck Sharp & Dohme de Espana S.A.
Josefa Valcarcel, 38
28027 Madrid / ES
Inventor(s)01 / BASILIO, Angela
Josefa Valcarcel 38
E-28027 Madrid / ES
02 / GENILLOUD, Olga
Josefa Valcarcel 38
E-28027 Madrid / ES
03 / JAYASURIYA, Hiranthi
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
04 / GONZALEZ, Ignacio
Josefa Valcarcel 38
E-28027 Madrid / ES
05 / SINGH, Sheo, B.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
06 / SALAZAR, Oscar
Josefa Valcarcel 38
E-28027 Madrid / ES
07 / WANG, Jun
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2007/09]
Representative(s)Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[N/P]
Former [2012/27]Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2007/09]Buchan, Gavin MacNicol, et al
Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon
Hertfordshire, EN11 9BU / GB
Application number, filing date05751778.120.05.2005
[2007/09]
WO2005US17832
Priority number, dateUS20040573899P24.05.2004         Original published format: US 573899 P
[2007/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005115400
Date:08.12.2005
Language:EN
[2005/49]
Type: A2 Application without search report 
No.:EP1756034
Date:28.02.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 08.12.2005 takes the place of the publication of the European patent application.
[2007/09]
Type: B1 Patent specification 
No.:EP1756034
Date:04.07.2012
Language:EN
[2012/27]
Search report(s)International search report - published on:US18.05.2006
(Supplementary) European search report - dispatched on:EP06.05.2010
ClassificationIPC:C07C69/00, A61K31/19, G01N33/554, A61K31/609
[2010/21]
CPC:
C07C235/78 (EP,US); A61K31/609 (EP,US); A61P31/04 (EP);
C12P13/02 (EP,US); C07C2603/70 (EP,US); Y02A50/30 (EP)
Former IPC [2007/09]C07C69/00, A61K31/19, G01N33/554
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/09]
Extension statesLV27.12.2006
TitleGerman:ANTIBIOTISCHE VERBINDUNG[2007/09]
English:ANTIBIOTIC COMPOUND[2007/09]
French:COMPOSE ANTIBIOTIQUE[2007/09]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase27.12.2006National basic fee paid 
27.12.2006Search fee paid 
27.12.2006Designation fee(s) paid 
27.12.2006Examination fee paid 
Examination procedure27.12.2006Examination requested  [2007/09]
29.10.2010Despatch of a communication from the examining division (Time limit: M04)
21.02.2011Reply to a communication from the examining division
23.01.2012Communication of intention to grant the patent
21.05.2012Fee for grant paid
21.05.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.10.2010
Opposition(s)05.04.2013No opposition filed within time limit [2013/24]
Fees paidRenewal fee
07.05.2007Renewal fee patent year 03
18.03.2008Renewal fee patent year 04
02.06.2009Renewal fee patent year 05
31.03.2010Renewal fee patent year 06
10.05.2011Renewal fee patent year 07
21.03.2012Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.05.2005
AT04.07.2012
BE04.07.2012
CY04.07.2012
CZ04.07.2012
DK04.07.2012
EE04.07.2012
FI04.07.2012
IT04.07.2012
LT04.07.2012
MC04.07.2012
PL04.07.2012
RO04.07.2012
SE04.07.2012
SI04.07.2012
SK04.07.2012
TR04.07.2012
BG04.10.2012
GR05.10.2012
ES15.10.2012
IS04.11.2012
PT05.11.2012
[2015/34]
Former [2015/32]AT04.07.2012
BE04.07.2012
CY04.07.2012
CZ04.07.2012
DK04.07.2012
EE04.07.2012
FI04.07.2012
IT04.07.2012
LT04.07.2012
MC04.07.2012
PL04.07.2012
RO04.07.2012
SE04.07.2012
SI04.07.2012
SK04.07.2012
TR04.07.2012
BG04.10.2012
GR05.10.2012
ES15.10.2012
IS04.11.2012
PT05.11.2012
Former [2014/03]AT04.07.2012
BE04.07.2012
CY04.07.2012
CZ04.07.2012
DK04.07.2012
EE04.07.2012
FI04.07.2012
IT04.07.2012
LT04.07.2012
MC04.07.2012
PL04.07.2012
RO04.07.2012
SE04.07.2012
SI04.07.2012
SK04.07.2012
BG04.10.2012
GR05.10.2012
ES15.10.2012
IS04.11.2012
PT05.11.2012
Former [2013/34]AT04.07.2012
BE04.07.2012
CY04.07.2012
CZ04.07.2012
DK04.07.2012
EE04.07.2012
FI04.07.2012
IT04.07.2012
LT04.07.2012
PL04.07.2012
RO04.07.2012
SE04.07.2012
SI04.07.2012
SK04.07.2012
BG04.10.2012
GR05.10.2012
ES15.10.2012
IS04.11.2012
PT05.11.2012
Former [2013/23]AT04.07.2012
BE04.07.2012
CY04.07.2012
CZ04.07.2012
DK04.07.2012
EE04.07.2012
FI04.07.2012
IT04.07.2012
LT04.07.2012
PL04.07.2012
RO04.07.2012
SE04.07.2012
SI04.07.2012
SK04.07.2012
GR05.10.2012
ES15.10.2012
IS04.11.2012
PT05.11.2012
Former [2013/22]AT04.07.2012
BE04.07.2012
CY04.07.2012
CZ04.07.2012
DK04.07.2012
EE04.07.2012
FI04.07.2012
LT04.07.2012
PL04.07.2012
SE04.07.2012
SI04.07.2012
GR05.10.2012
ES15.10.2012
IS04.11.2012
PT05.11.2012
Former [2013/21]AT04.07.2012
BE04.07.2012
CY04.07.2012
DK04.07.2012
FI04.07.2012
LT04.07.2012
PL04.07.2012
SE04.07.2012
SI04.07.2012
GR05.10.2012
IS04.11.2012
PT05.11.2012
Former [2013/13]AT04.07.2012
BE04.07.2012
CY04.07.2012
FI04.07.2012
LT04.07.2012
PL04.07.2012
SE04.07.2012
SI04.07.2012
GR05.10.2012
IS04.11.2012
PT05.11.2012
Former [2013/12]AT04.07.2012
BE04.07.2012
CY04.07.2012
FI04.07.2012
LT04.07.2012
PL04.07.2012
SE04.07.2012
SI04.07.2012
GR05.10.2012
IS04.11.2012
Former [2013/11]AT04.07.2012
BE04.07.2012
CY04.07.2012
FI04.07.2012
LT04.07.2012
PL04.07.2012
SI04.07.2012
GR05.10.2012
IS04.11.2012
Former [2013/10]AT04.07.2012
BE04.07.2012
CY04.07.2012
FI04.07.2012
LT04.07.2012
SI04.07.2012
IS04.11.2012
Former [2013/09]AT04.07.2012
BE04.07.2012
FI04.07.2012
LT04.07.2012
SI04.07.2012
Former [2013/08]AT04.07.2012
BE04.07.2012
LT04.07.2012
SI04.07.2012
Former [2013/07]AT04.07.2012
SI04.07.2012
Former [2012/51]SI04.07.2012
Documents cited:Search[AP]WO2005009391  (MERCK & CO INC [US], et al) [AP] 1-7 * claims 1-8 *;
 [A]  - THOMPSON PAUL E ET AL, "Antimalarial activity of .beta.-resorcylic acid and analogs and reversal by p-hydroxybenzoic acid", ANTIBIOTICS AND CHEMOTHERAPY, ANTIBIOTICS AND CHEMOTHERAPY, NORTHFIELD, IL, US, (19530101), vol. 3, ISSN 0570-3123, pages 399 - 408, XP009132458 [A] 1-7 * the whole document *
 [L]  - WANG JUN ET AL, "Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200705), vol. 104, no. 18, ISSN 0027-8424, pages 7612 - 7616, XP002579060 [L] 1-7 * figure 1; table 1 *

DOI:   http://dx.doi.org/10.1073/pnas.0700746104
International search[A]US2891091  (MARVIN DARRACH, et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.